The B4GALNT1 Gene SPG26 Genetic Test is a specialized diagnostic tool designed to detect mutations in the B4GALNT1 gene, which are associated with Spastic Paraplegia 26 (SPG26), a rare neurodegenerative disorder. This condition is characterized by progressive weakness and spasticity of the lower limbs, and it falls under the category of hereditary spastic paraplegias. The test is particularly crucial for individuals showing symptoms of the disease or those with a family history of SPG26, as it can provide definitive genetic evidence of the condition.
Conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services, the test involves analyzing the patient's DNA to identify any mutations in the B4GALNT1 gene that might lead to the disorder. The process is meticulous and requires a sample of the patient's blood or saliva, from which DNA is extracted and examined for the specific genetic changes.
The cost of the B4GALNT1 Gene SPG26 Genetic Test at DNA Labs UAE is set at 4400 AED. While this may represent a significant investment, the value of the test lies in its ability to provide individuals and families with crucial information regarding the genetic basis of SPG26, facilitating informed decisions about treatment options and management of the disorder. It also aids in genetic counseling for affected families, offering insights into the risk of passing the condition to future generations.
The DDHD1 gene SPG28 genetic test is a specialized diagnostic tool designed to detect mutations in the DDHD1 gene, which are associated with a rare form of hereditary spastic paraplegia (HSP), specifically SPG28. HSPs are a group of inherited disorders characterized by progressive stiffness and contraction (spasticity) in the lower limbs, and SPG28 is one of its autosomal recessive subtypes.
This genetic test involves analyzing the patient's DNA to identify any alterations in the DDHD1 gene that may lead to the disease. It is a crucial step in confirming the diagnosis of SPG28, allowing for a better understanding of the condition, informed genetic counseling, and personalized management plans for affected individuals.
The test is offered by DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the DDHD1 gene SPG28 genetic test is 4400 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing essential insights for patients and their families dealing with the challenges of hereditary spastic paraplegia.
The KIF1A Gene SPG30 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the KIF1A gene, which are associated with SPG30, a form of hereditary spastic paraplegia. This condition affects the nervous system, leading to progressive weakness and stiffness of the legs. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic alterations in the KIF1A gene, helping in the diagnosis, management, and understanding of the condition. By identifying these genetic mutations, healthcare providers can offer more personalized treatment plans and advice for patients and their families on the prognosis and possible genetic counseling needs.
The REEP1 gene SPG31 genetic test is a specialized diagnostic tool aimed at detecting mutations in the REEP1 gene, which are associated with Spastic Paraplegia 31 (SPG31). SPG31 is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive stiffness and weakness of the legs. Mutations in the REEP1 gene disrupt the normal function of neurons in the spinal cord, leading to the symptoms associated with the condition.
The test is conducted by DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. By analyzing a sample of the patient's DNA, the test can identify specific mutations in the REEP1 gene that are linked to SPG31. This information is crucial for accurate diagnosis, enabling healthcare providers to offer appropriate genetic counseling and tailor management strategies to the individual's needs.
The cost of the REEP1 gene SPG31 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the REEP1 gene. For patients and families affected by hereditary spastic paraplegia, this test represents a critical step towards understanding their condition and making informed decisions about their care.
The ZFYVE27 Gene SPG33 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ZFYVE27 gene, which are linked to the development of spastic paraplegia 33 (SPG33), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, affecting mobility and daily activities. The test involves analyzing the patient's DNA to detect any genetic anomalies associated with SPG33, providing crucial information for diagnosis, management, and family planning.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is available for a cost of 4400 AED. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure accurate and reliable results. By opting for the ZFYVE27 Gene SPG33 Genetic Test, patients and their families can gain valuable insights into their genetic health, paving the way for tailored treatment plans and informed decisions about their future.
The FA2H gene SPG35 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the FA2H gene, which are associated with a rare form of hereditary spastic paraplegia (HSP), known as SPG35. This condition is characterized by progressive weakness and stiffness of the legs, and in some cases, it may also affect the arms and other parts of the body. The genetic test is crucial for accurate diagnosis, enabling targeted management and genetic counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the FA2H gene SPG35 genetic test involves analyzing the patient's DNA to identify mutations in the FA2H gene. This gene plays a significant role in the metabolism of certain fats in the brain and nervous system, and mutations can lead to the neurological symptoms observed in SPG35.
The cost of the FA2H gene SPG35 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing process, including the extraction of DNA, the use of advanced sequencing technologies to scrutinize the FA2H gene, and the expert analysis required to interpret the results accurately. While the cost may seem high, the test offers invaluable insights for affected individuals, guiding treatment options and helping families understand the risk of inheritance.
The PNPLA6 gene SPG39 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the PNPLA6 gene, which are associated with spastic paraplegia 39 (SPG39). This condition is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The test is crucial for individuals showing symptoms of SPG39 or those with a family history of the condition, as it aids in confirming the diagnosis, understanding the disease progression, and making informed decisions regarding management and treatment.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA sample to detect any genetic abnormalities present in the PNPLA6 gene. The process is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers.
The cost of the PNPLA6 gene SPG39 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the PNPLA6 gene. Patients seeking this test can expect a seamless and supportive experience, with guidance from skilled professionals throughout the testing process.
The ATL1 gene SPG3A genetic test is a specialized diagnostic tool designed to identify mutations in the ATL1 gene, which are known to cause a form of hereditary spastic paraplegia (HSP) known as SPG3A. This condition is characterized by progressive stiffness and weakness in the legs due to the degeneration of nerve pathways responsible for movement control. Early detection through genetic testing can be crucial for managing symptoms, planning treatment strategies, and understanding the risk of passing the condition to future generations.
DNA Labs UAE offers this specific genetic test, providing a comprehensive analysis of the ATL1 gene to identify any mutations associated with SPG3A. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory facility, ensuring high accuracy and reliability of the results. Individuals who have a family history of HSP or exhibit symptoms related to the condition may consider undergoing this test for a clear diagnosis. The results can also offer valuable insights for families planning children and looking to assess genetic risks.
The SPAST gene SPG4 genetic test is a specialized diagnostic tool designed to identify mutations in the SPAST gene, which is primarily associated with Spastic Paraplegia 4 (SPG4). SPG4, also known as Hereditary Spastic Paraplegia 4, is a neurological disorder characterized by progressive weakness and stiffness of the legs. The SPAST gene plays a crucial role in the development and maintenance of the nervous system, and mutations in this gene are the most common cause of autosomal dominant hereditary spastic paraplegia.
Conducted at DNA Labs UAE, this genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the SPAST gene that may lead to the condition. Early diagnosis through genetic testing can be vital for the management and treatment of SPG4, allowing for personalized treatment plans and genetic counseling for affected individuals and their families.
The cost of the SPAST gene SPG4 genetic test at DNA Labs UAE is 4400 AED. This price may cover the collection of the sample, the genetic analysis, and the provision of a detailed report by healthcare professionals. It's important for patients considering this test to consult with their healthcare provider to understand the implications of the results and the next steps in the case of a positive finding.
The SLC33A1 gene, associated with SPG42 (Spastic Paraplegia 42), is crucial for understanding and managing this rare hereditary disorder. SPG42 is characterized by progressive weakness and stiffness of the legs, resulting from the degeneration of nerve cells that control muscle movement and coordination. The genetic test for SPG42, focusing on the SLC33A1 gene, is an essential diagnostic tool for individuals showing symptoms of this condition or those with a family history of hereditary spastic paraplegia.
Conducted at DNA Labs UAE, the test for the SLC33A1 gene associated with SPG42 involves analyzing the patient's DNA to identify mutations in the SLC33A1 gene that could lead to the disorder. This precise genetic testing can confirm a diagnosis of SPG42, allowing for appropriate management and treatment plans to be developed. It can also provide valuable information for family planning and genetic counseling for affected families.
The cost of the SLC33A1 gene SPG42 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the SLC33A1 gene that are responsible for SPG42. By opting for this test, patients and their families can gain insights into the genetic basis of the condition, enabling informed decisions about care and support.
